Watchdog Opens Probe Into FDA Handling of Abbott Formula Recall

June 2, 2022, 6:51 PM UTC

A Health and Human Services Department watchdog will review FDA’s actions leading up to the infant formula recall at the Abbott facility in February 2022, the department says on website.

  • Move seeks to determine whether FDA followed procedures for conducting inspections of the manufacturing facility and for overseeing Abbott’s infant formula recall
  • NOTE: Baby-Formula Makers Tell Biden They Knew Shortages Would Be Dire

To contact the reporter on this story:
Maria Luiza Rabello in washington at mrabello@bloomberg.net

To contact the editors responsible for this story:
Kasia Klimasinska at kklimasinska@bloomberg.net

Megan Howard, Maria Luiza Rabello

© 2022 Bloomberg ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.